These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

123 related articles for article (PubMed ID: 15385953)

  • 21. Conditionally replicative adenovirus vector carrying TRAIL gene for enhanced oncolysis of human hepatocellular carcinoma.
    Ye X; Lu Q; Zhao Y; Ren Z; Ren XW; Qiu QH; Tong Y; Liang M; Hu F; Chen HZ
    Int J Mol Med; 2005 Dec; 16(6):1179-84. PubMed ID: 16273304
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Mesenchymal stem cells as a vehicle for targeted delivery of CRAds to lung metastases of breast carcinoma.
    Stoff-Khalili MA; Rivera AA; Mathis JM; Banerjee NS; Moon AS; Hess A; Rocconi RP; Numnum TM; Everts M; Chow LT; Douglas JT; Siegal GP; Zhu ZB; Bender HG; Dall P; Stoff A; Pereboeva L; Curiel DT
    Breast Cancer Res Treat; 2007 Oct; 105(2):157-67. PubMed ID: 17221158
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Enhanced efficacy of Escherichia coli nitroreductase/CB1954 prodrug activation gene therapy using an E1B-55K-deleted oncolytic adenovirus vector.
    Chen MJ; Green NK; Reynolds GM; Flavell JR; Mautner V; Kerr DJ; Young LS; Searle PF
    Gene Ther; 2004 Jul; 11(14):1126-36. PubMed ID: 15164095
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Oncolytic adenovirus delivering herpes simplex virus thymidine kinase suicide gene reduces the growth of human retinoblastoma in an in vivo mouse model.
    Ji X; Zhang J; Cheng L; Wei F; Li H; Liu X; Chen X; Li C; Wang Y; Huang Q
    Exp Eye Res; 2009 Aug; 89(2):193-9. PubMed ID: 19328781
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Conditionally replicative adenovirus expressing p53 exhibits enhanced oncolytic potency.
    van Beusechem VW; van den Doel PB; Grill J; Pinedo HM; Gerritsen WR
    Cancer Res; 2002 Nov; 62(21):6165-71. PubMed ID: 12414643
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Selective intratumoral amplification of an antiangiogenic vector by an oncolytic virus produces enhanced antivascular and anti-tumor efficacy.
    Thorne SH; Tam BY; Kirn DH; Contag CH; Kuo CJ
    Mol Ther; 2006 May; 13(5):938-46. PubMed ID: 16469543
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Immune gene-viral therapy with triplex efficacy mediated by oncolytic adenovirus carrying an interferon-gamma gene yields efficient antitumor activity in immunodeficient and immunocompetent mice.
    Su C; Peng L; Sham J; Wang X; Zhang Q; Chua D; Liu C; Cui Z; Xue H; Wu H; Yang Q; Zhang B; Liu X; Wu M; Qian Q
    Mol Ther; 2006 May; 13(5):918-27. PubMed ID: 16497559
    [TBL] [Abstract][Full Text] [Related]  

  • 28. E1A, E1B double-restricted replicative adenovirus at low dose greatly augments tumor-specific suicide gene therapy for gallbladder cancer.
    Fukuda K; Abei M; Ugai H; Kawashima R; Seo E; Wakayama M; Murata T; Endo S; Hamada H; Hyodo I; Yokoyama KK
    Cancer Gene Ther; 2009 Feb; 16(2):126-36. PubMed ID: 18818710
    [TBL] [Abstract][Full Text] [Related]  

  • 29. An ex vivo human model system to evaluate specificity of replicating and non-replicating gene therapy agents.
    Rots MG; Elferink MG; Gommans WM; Oosterhuis D; Schalk JA; Curiel DT; Olinga P; Haisma HJ; Groothuis GM
    J Gene Med; 2006 Jan; 8(1):35-41. PubMed ID: 16044485
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Chlorpromazine and apigenin reduce adenovirus replication and decrease replication associated toxicity.
    Kanerva A; Raki M; Ranki T; Särkioja M; Koponen J; Desmond RA; Helin A; Stenman UH; Isoniemi H; Höckerstedt K; Ristimäki A; Hemminki A
    J Gene Med; 2007 Jan; 9(1):3-9. PubMed ID: 17149790
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Inhibition of NF-kappaB enhances the cytotoxicity of virus-directed enzyme prodrug therapy and oncolytic adenovirus cancer gene therapy.
    Palmer DH; Chen MJ; Searle PF; Kerr DJ; Young LS
    Gene Ther; 2005 Aug; 12(15):1187-97. PubMed ID: 15800660
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Tetracycline-inducible promoter-based conditionally replicative adenoviruses for the control of viral replication.
    Zhang H; Takayama K; Zhang L; Uchino J; Harada A; Harada T; Hisasue J; Nakagaki N; Zhou C; Nakanishi Y
    Cancer Gene Ther; 2009 May; 16(5):415-22. PubMed ID: 19148207
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Conditionally replicating adenoviruses as anticancer agents and ways to improve their efficacy.
    Oosterhoff D; van Beusechem VW
    J Exp Ther Oncol; 2004 Apr; 4(1):37-57. PubMed ID: 15255291
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Survivin promoter-based conditionally replicative adenoviruses target cholangiocarcinoma.
    Zhu ZB; Chen Y; Makhija SK; Lu B; Wang M; Rivera AA; Yamamoto M; Wang S; Siegal GP; Curiel DT; McDonald JM
    Int J Oncol; 2006 Nov; 29(5):1319-29. PubMed ID: 17016667
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Concurrent delivery of GM-CSF and B7-1 using an oncolytic adenovirus elicits potent antitumor effect.
    Choi KJ; Kim JH; Lee YS; Kim J; Suh BS; Kim H; Cho S; Sohn JH; Kim GE; Yun CO
    Gene Ther; 2006 Jul; 13(13):1010-20. PubMed ID: 16525479
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Functional interactions of antiapoptotic proteins and tumor necrosis factor in the context of a replication-competent adenovirus.
    Liu TC; Wang Y; Hallden G; Brooks G; Francis J; Lemoine NR; Kirn D
    Gene Ther; 2005 Sep; 12(17):1333-46. PubMed ID: 15920462
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Infectivity enhancement for adenoviral transduction of canine osteosarcoma cells.
    Le LP; Rivera AA; Glasgow JN; Ternovoi VV; Wu H; Wang M; Smith BF; Siegal GP; Curiel DT
    Gene Ther; 2006 Mar; 13(5):389-99. PubMed ID: 16292351
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Production of an EGFR targeting molecule from a conditionally replicating adenovirus impairs its oncolytic potential.
    Hemminki A; Wang M; Hakkarainen T; Desmond RA; Wahlfors J; Curiel DT
    Cancer Gene Ther; 2003 Aug; 10(8):583-8. PubMed ID: 12872139
    [TBL] [Abstract][Full Text] [Related]  

  • 39. From gene therapy to virotherapy for ovarian cancer.
    Stoff-Khalili MA; Dall P; Curiel DT
    Minerva Ginecol; 2004 Dec; 56(6):503-14. PubMed ID: 15729203
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Antitumor activity of an oncolytic adenovirus-delivered oncogene small interfering RNA.
    Zhang YA; Nemunaitis J; Samuel SK; Chen P; Shen Y; Tong AW
    Cancer Res; 2006 Oct; 66(19):9736-43. PubMed ID: 17018633
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.